The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A SEER-based multiethnic picture of cholangiocarcinoma in the United States pre and post the advent of gemcitabine/cisplatin.
 
Kabir Mody
Consulting or Advisory Role - Celgene; Genentech/Roche; Merrimack
Research Funding - ARIAD; FibroGen; MedImmune; Senhwa Biosciences; TRACON Pharma
 
Samuel O Antwi
No Relationships to Disclose
 
David O Hodge
No Relationships to Disclose
 
Zahara Meghji
No Relationships to Disclose
 
Sikander Ailawadhi
Consulting or Advisory Role - Amgen; Novartis; Takeda
Research Funding - Pharmacyclics (Inst)
Travel, Accommodations, Expenses - Amgen; Novartis; Takeda
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Celgene; Genentech/Roche; Glenmark; Lilly; Merrimack; NCCN; Pfizer; Research to Practice; Sirtex Medical; Taiho Pharmaceutical
Other Relationship - Exelixis; Merck; Polaris
 
Lewis R. Roberts
No Relationships to Disclose